Contact this trialFirst, we need to learn more about you.
Chemotherapy
FHD-609 for Synovial Sarcoma
Recruiting1 awardPhase 1
Houston, Texas
This trial tests a new drug called FHD-609, given through an IV, in patients with severe forms of cancer. Researchers aim to see if it is safe and effective by studying how the body processes the drug and its impact on tumors.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service